Acceleron Pharma
XLRN
#1917
Rank
ยฃ7.98 B
Marketcap
ยฃ130.52
Share price
0.00%
Change (1 day)
13,606.31%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: ยฃ7.98 Billion

As of February 2026 Acceleron Pharma has a market cap of ยฃ7.98 Billion. This makes Acceleron Pharma the world's 1917th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022ยฃ9.03 B11.58%
2021ยฃ8.09 B43.2%
2020ยฃ5.65 B163.29%
2019ยฃ2.14 B35.33%
2018ยฃ1.58 B11.73%
2017ยฃ1.42 B81.95%
2016ยฃ0.78 B-28.78%
2015ยฃ1.09 B35.06%
2014ยฃ0.81 B19.25%
2013ยฃ0.68 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ419.82 B 5,159.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ112.30 B 1,306.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ147.91 B 1,753.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ60.23 B 654.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ0.10 B-98.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
ยฃ15.26 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
ยฃ35.53 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA